Tag: HIV Research

  • 2025 Health in Review: Challenges and Triumphs

    The 2025 Health in Review for the South African healthcare sector began with a seismic geopolitical shock. It is ending with a mixed scorecard of administrative failures and clinical triumphs. The tone for the year was set in January. This occurred when newly inaugurated US President Donald Trump signed an executive order pausing all foreign aid for 90 days. The…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Medical Research in SA: The Impact of NIH Cuts

    The state of medical research in SA is currently at a crossroads. A sudden and significant reduction in grants from the United States, particularly from the NIH, poses a severe threat to medical research in South Africa. The key question is whether the South African government will view this challenge as an opportunity for renewed local investment. South Africa is…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Lenacapavir injection: The new frontier in HIV prevention

    At the 5th HIV Research for Prevention Conference (HIVR4P) in Peru, groundbreaking data on the lenacapavir injection revealed its remarkable efficacy in HIV prevention. With a single injection every six months, the drug completely halted new HIV infections among women and girls. It achieved a 96% risk reduction for other gender-diverse individuals aged 16 and up. Despite lenacapavir’s transformative potential,…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in